In this special report, eyeforpharma examines how pharma can use key account management (KAM) as a strategic sales and marketing tool.
David Wright, director of Imonic Ltd and conference chair of eyeforpharma’s recent KAM Europe conference, outlines the insights gained from the event
Phil Taylor explores how reps can shift their sales strategies from traditional detailing to Key Account Management
Key account management (KAM) requires high-level capabilities, both from individuals and from organisations. Phil Taylor explores whether the pharmaceutical sector is lagging behind other industries in adopting the approach
Don't write off the sales rep just yet
Traditional sales reps can still play vital roles in the transition to KAM. Phil Taylor reports
Pharma and KAM: Key Account Management needs team spirit
A new eyeforpharma report finds that teamwork is essential if KAM is to offer a strategic response to cost-constrained healthcare systems
Pharma and KAM: Delivering value in key account management
A new eyeforpharma report finds that constructing and delivering value propositions through key account management strategies may be one of the few opportunities left to boost pharmaceutical sales in established markets
Pharma and KAM: The role of objectives and metrics
A new eyeforpharma report suggests pharma still has not transitioned to new measures that fully reflect the objectives and outcomes of KAM programs
Pharma sales: KAM as a market access tool
Peter Mansell reports on why key account management (KAM) is coming into its own as a market access strategy
What pharma can learn from the use of KAM in other industries
Dan Goldsmith, general manager of Veeva Europe, and Patrick Hart, CRM partner at Accenture Management Consulting, on why key account management's time has come
How to make KAM work for the pharma sales force
Craig Dixon explores how, with the right interpersonal, networking, and team-building skills, Key Account Management can deliver value to customers
Pharma sales: Clearing up KAM confusion
Ben Manuele explains why a common understanding of KAM across an organization is essential to formulating successful customer strategies
Chris Morgan, a principal at ZS Associates, explains the keys to successful key account management
blog comments powered by DisqusAndrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs